BioNexus Gene Lab Corp. Increase (Decrease) in Income Taxes Receivable
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) in Income Taxes Receivable of -$36.85 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2024-11-15
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for the quarter ending 2024-09-30 was -$87.06K, a 6482.48% decline year-over-year.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for the quarter ending 2024-06-30 was $57.02K.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for the quarter ending 2024-03-31 was -$6.81K.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for the quarter ending 2023-12-31 was -$16.74K.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for fiscal 2023 was -$44.65K, a 422.00% decline from fiscal 2022.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for fiscal 2022 was $13.87K, a 78.67% decline from fiscal 2021.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for fiscal 2021 was $65.01K, a 119.89% increase from fiscal 2020.
- BioNexus Gene Lab Corp. increase (decrease) in income taxes receivable for fiscal 2020 was $29.56K.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 3 month as first filed | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 6 month as first filed | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 9 month as first filed | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$87.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$30.04K derived: sum of 2 quarters · filed 2024-11-15 | -$36.85K 10-Q · filed 2024-11-15 | -$53.59K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2024-06-30 | $57.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $50.21K 10-Q · filed 2024-08-14 | $33.47K derived: sum of 3 quarters · filed 2024-08-14 | $34.83K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2024-03-31 | -$6.81K 10-Q · filed 2024-05-15 | -$23.55K derived: sum of 2 quarters · filed 2024-05-15 | -$22.19K derived: sum of 3 quarters · filed 2024-11-15 | -$47.92K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-12-31 | -$16.74K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$15.38K derived: sum of 2 quarters · filed 2024-11-15 | -$41.11K derived: sum of 3 quarters · filed 2024-11-15 | -$44.65K 10-K · filed 2024-04-16 | |||
| 2023-09-30 | $1.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$24.36K derived: sum of 2 quarters · filed 2024-11-15 | -$27.90K 10-Q · filed 2024-11-15 | -$167.25K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | -$25.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$29.27K 10-Q · filed 2024-08-14 | $29.27K 10-Q · filed 2023-08-16 | -$168.61K derived: sum of 3 quarters · filed 2024-08-14 | -$77.84K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$3.54K 10-Q · filed 2024-05-15 | -$142.88K derived: sum of 2 quarters · filed 2024-05-15 | -$52.11K derived: sum of 3 quarters · filed 2024-05-15 | -$17.60K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$139.34K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$48.57K derived: sum of 2 quarters · filed 2024-04-16 | -$14.06K derived: sum of 3 quarters · filed 2024-04-16 | $13.87K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | $90.77K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $125.28K derived: sum of 2 quarters · filed 2024-03-26 | $153.21K 10-Q/A · filed 2024-03-26 | -$153.21K 10-Q · filed 2022-11-14 | $129.22K derived: sum of 4 quarters · filed 2024-03-26 | ||
| 2022-06-30 | $34.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $62.44K 10-Q · filed 2023-08-16 | -$62.44K 10-Q · filed 2022-08-15 | $38.44K derived: sum of 3 quarters · filed 2023-08-16 | $83.19K derived: sum of 4 quarters · filed 2023-08-16 | ||
| 2022-03-31 | $27.92K 10-Q · filed 2023-05-09 | $3.93K derived: sum of 2 quarters · filed 2023-05-09 | $48.68K derived: sum of 3 quarters · filed 2023-05-09 | $60.00K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$23.99K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $20.76K derived: sum of 2 quarters · filed 2023-03-31 | $32.08K derived: sum of 3 quarters · filed 2023-03-31 | $65.01K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $44.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $56.07K derived: sum of 2 quarters · filed 2022-11-14 | $89.00K 10-Q · filed 2022-11-14 | $196.78K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $11.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $44.25K 10-Q · filed 2022-08-15 | $152.03K derived: sum of 3 quarters · filed 2022-08-15 | $118.50K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $32.93K 10-Q · filed 2022-05-16 | -$32.93K 10-Q · filed 2021-05-18 | $140.71K derived: sum of 2 quarters · filed 2022-05-16 | $107.18K derived: sum of 3 quarters · filed 2022-05-16 | $102.45K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $107.78K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $74.25K derived: sum of 2 quarters · filed 2022-04-06 | $69.52K derived: sum of 3 quarters · filed 2022-04-06 | $29.56K 10-K · filed 2022-04-06 | |||
| 2020-09-30 | -$33.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$38.26K derived: sum of 2 quarters · filed 2021-11-15 | -$78.22K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | -$4.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$44.68K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | -$39.95K 10-Q · filed 2021-05-18 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |